Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Cochlear Limited
  6. Summary
    COH   AU000000COH5

COCHLEAR LIMITED

(COH)
  Report
End-of-day quote. End-of-day quote Australian Stock Exchange - 06/18
246.72 AUD   +1.38%
05/31COCHLEARá : Promotes Non-Executive Director to Chairman
MT
05/14APPLIED GENETIC TECHNOLOGIESá : Otonomy's OTO-825 Gene Therapy Saves Hearing Loss in Preclinical Models
MT
05/09VIRTUS HEALTHá : Names CFO
MT
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
06/11/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
235.32 239.76 241.97 243.37 246.72 Last
110654 146695 185100 149177 211338 Volume
+0.29% +1.89% +0.92% +0.58% +1.38% Change
Financials
Sales 2021 1 500 M 1 122 M 1 122 M
Net income 2021 318 M 238 M 238 M
Net cash position 2021 471 M 352 M 352 M
P/E ratio 2021 52,2x
Yield 2021 0,95%
Sales 2022 1 700 M 1 272 M 1 272 M
Net income 2022 301 M 225 M 225 M
Net cash position 2022 532 M 398 M 398 M
P/E ratio 2022 53,5x
Yield 2022 1,32%
Capitalization 16 220 M 12 141 M 12 133 M
EV / Sales 2021 10,5x
EV / Sales 2022 9,23x
Nbr of Employees 4 000
Free-Float 99,3%
More Financials
Company
Cochlear Ltd is an Australia-based company that provides implantable hearing solutions. The Company provides bone conduction implants for people with conductive hearing loss, mixed hearing loss and single-sided deafness. Its segments include Americas, EMEA and Asia Pacific. Americas includes the United States, Canada and Latin America. EMEA includes Europe, Middle East and Africa. Asia Pacific includes Australasia... 
More about the company
Ratings of Cochlear Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about COCHLEAR LIMITED
05/31COCHLEARá : Promotes Non-Executive Director to Chairman
MT
05/14APPLIED GENETIC TECHNOLOGIESá : Otonomy's OTO-825 Gene Therapy Saves Hearing Los..
MT
05/09VIRTUS HEALTHá : Names CFO
MT
03/31Australia shares notch best month in four as China data lifts rebound bets
RE
03/25COCHLEAR LIMITED : Ex-dividend day for interim dividend
FA
03/24Australia shares reverse losses as export-reliant healthcare stocks shine
RE
03/18Tech, healthcare drag Australian shares lower as U.S. yields tick up
RE
02/19Australian Shares Fall Amid Slower Economic Recovery Concerns; Morrison Blast..
MT
02/18COCHLEARá : Lowers Interim Dividend as July-December 2020 Underlying Profit Retr..
MT
2020COCHLEARá : US Court Denies Cochlear's Appeal in Patent Infringement Case
MT
2020Australia shares fall on COVID-19 vaccine production halt, post sixth weekly ..
RE
2020Australia shares recover ground ahead of cenbank decision; China tensions wei..
RE
2020Xero's Net Profit Jumps as Customer Growth Continues in Pandemic -- Update
DJ
2020Australia shares end at over 7-mth high as restrictions ease in Victoria
RE
2020Australia shares fall as record virus cases dent investor sentiment
RE
More news
News in other languages on COCHLEAR LIMITED
2020Morning Briefing - Markt Schweiz
2020Sonova obtient gain de cause dans une affaire de brevets aux USA
2020Aktien Schweiz Schluss: SMI stellt neues Rekordhoch auf
2020Aktien Schweiz: SMI setzt Rekordjagd fort - Coronasorgen ebben ab
2020Aktien Schweiz Eröffnung: SMI erneut auf Rekordhoch
More news
Chart COCHLEAR LIMITED
Duration : Period :
Cochlear Limited Technical Analysis Chart | COH | AU000000COH5 | MarketScreener
Technical analysis trends COCHLEAR LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 214,50 AUD
Last Close Price 246,72 AUD
Spread / Highest target 1,33%
Spread / Average Target -13,1%
Spread / Lowest Target -35,1%
EPS Revisions
Managers and Directors
NameTitle
Diggory William Howitt President, CEO, Executive Director & MD
Stuart Sayers Chief Financial Officer & President-Services
Roderick Holliday-Smith Chairman
Jan Janssen Chief Technology Officer
David Hackshall Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
COCHLEAR LIMITED30.54%12 097
STRAUMANN HOLDING AG36.69%24 463
SONOVA HOLDING AG43.35%22 671
DEMANT A/S45.89%13 466
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.81.96%4 883
ÖSSUR HF.-4.64%3 126